Agreements with AstraZeneca and the University of Nebraska Medical Center showcase new workflows to improve the throughput, robustness and standardization of clinical biomarker analysis
Trial provides the strongest evidence yet that simple blood tests known as liquid biopsies can benefit women with breast cancer by tracking their disease as it evolves
Join Clinical Lab Manager and our panel of experts as we discuss how clinical mass spectrometry is advancing the transition from detecting illness to quantifying wellness